Jpmorgan Chase & Co »

Cortexyme shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Cortexyme (QNCX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Cortexyme

Tip: Access up to 7 years of quarterly data

All positions including Cortexyme held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cortexyme by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $425 548 0.78
2024-06-30 $351 469 0.75
2024-03-31 $496 469 1.06
2023-12-31 $491 469 1.05
2023-09-30 $524 469 1.12
2023-06-30 $705 469 1.51
2023-03-31 $1.0k 469 2.13
2022-12-31 $0 469 0.00
2022-06-30 $1.3M 567k 2.28
2022-03-31 $3.7M 590k 6.20
2021-12-31 $140k 10k 13.89
2021-03-31 $321k 8.9k 36.11
2020-12-31 $457k 17k 26.55
2020-09-30 $539k 11k 50.32
2020-06-30 $481k 10k 46.34
2020-03-31 $655k 14k 45.66
2019-12-31 $673k 12k 56.08
2019-09-30 $83k 3.3k 25.13
2019-06-30 $78k 1.9k 39.97